在患有三阴性乳腺癌的患者中,种族和民族的ERBB2-低表达
Astrid Botty van den Bruele1,2, Kerri-Anne Crowell2,3, Samantha M Thomas2,3
1Department of Surgery, Duke University School of Medicine, Durham, North Carolina.
JAMA network open
|June 11, 2025
概括
三重阴性乳腺癌 (TNBC) 结果因ERBB2低表达和种族而异. 低ERBB2与总体较低的病理完整反应 (pCR) 有关,但在不同患者群体中,生存率有很大差异.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 健康差异 在健康上的差异
背景情况:
- 在三阴性乳腺癌 (TNBC) 结果中的种族和种族差异已被记录.
- 瘤生物学,包括ERBB2表达,可能会影响这些差异.
- 在不同种族和种族群体的TNBC结果中ERBB2-低表达的作用需要进一步研究.
研究的目的:
- 为了确定TNBC中ERBB2-低表达是否因种族和种族而异.
- 评估ERBB2-低表达与TNBC患者的病理完整反应 (pCR) 和整体存活 (OS) 之间的关联.
- 探索这些关联如何在种族和种族群体之间存在差异.
主要方法:
- 使用国家癌症数据库 (2010-2019) 进行回顾性队列研究.
- 包括接受新辅助化疗治疗的I-III期TNBC的成年女性患者.
- 根据免疫组织化学得分 (1+或2+) 定义的ERBB2-低和非增强的in situ杂交;ERBB2-零定义的IHC 0.
主要成果:
- 在31,888名TNBC患者中,超过一半的ERBB2表达低.
- 低ERBB2表达与较低的pCR率 (28.6%与30.8%,P<.001) 相关.
- 西班牙裔患者在ERBB2状态中表现出更高的ERBB2-零TNBC率和更高的PCR率. 无论ERBB2状态如何,黑人患者的pCR和OS都较低. 与ERBB2-零相比,亚裔和白人患者的ERBB2-低表达显示了延长的OS.
结论:
- 低ERBB2表达及其对TNBC结果的影响在种族和种族群体之间有很大差异.
- 这些发现强调了需要研究ERBB2低表达在多样化的TNBC患者群体的生物学基础.
- 了解这些变异对于解决乳腺癌治疗中的健康差异至关重要.
相关概念视频
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


